Icu Medical IncICUI
ASignal's systematic analysis rates ICUI as Neutral.
Reflects the latest available analysis · analyzed Aug 27, 2026
The case on ICUI
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI near oversold level (32.56) suggesting potential reversal
- Current ratio of 2.43x indicates solid short-term financial health
- Debt-to-equity ratio of 0.60x is within acceptable range
- Positive free cash flow of $163.56M
- Forward P/E of 18.15x is more reasonable than current P/E
- MACD below signal line with negative histogram indicating bearish momentum
- Price below 20-day SMA and EMA, signaling near-term downtrend
- Extremely high current P/E ratio of 148.39x
- Negative earnings growth of -46.90% YoY
- Low ROE of 1.41% indicating poor capital efficiency
- No Reddit mentions, suggesting lack of retail investor interest
See the full verdict on ICUI
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ICUI
Most investors never get a second opinion, let alone several. ASignal runs ICUI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.